Lipocine Inc (LPCN) Stock Price, Quote & News

Company Profile

Lipocine Inc., a clinical-stage biopharmaceutical company, engages in the research and development for the delivery of drugs for the treatment of central nervous system (CNS) disorders. Its lead product candidate is TLANDO, an oral testosterone replacement therapy (TRT) comprising testosterone undecanoate. The company's pipeline candidates also include LPCN 1111 (TLANDO XR), a next-generation long-acting oral product candidate for TRT; LPCN 1148, a novel prodrug of testosterone and testosterone...

Industry: Biotechnology

Sector: Healthcare

Phone: 801 994 7383

Fax: 801 994 7388

Website: www.lipocine.com

Address:

675 Arapeen Drive, Suite 202, Salt Lake City, United States

Ma_pooperz Feb. 3 at 9:38 PM

$LPCN If you ask any woman/mom about childbirth you will almost always hear concern or experience with post partum depression, it affects 5%-50% of pregnancies. Currently zero accessible treatments in terms of time and money.

0 · Reply

az2001 Feb. 3 at 7:48 PM

$LPCN Took this opportunity to load up some more before upcoming catalysts

2 · Reply

JackLewisLPCN Feb. 3 at 6:44 PM

$LPCN I would officially be surprised if it dropped too far under $8. There isn't enough room between now and April and there should be a run to results, right? Feels like it would be kinda crazy for shares to not be snapped up at $8. Like, conservatively it should be near $12 around results, right?

3 · Reply

dbatech99 Feb. 2 at 11:21 PM

$LPCN islands in the stream chart? 🤮

0 · Reply

steven1x Feb. 2 at 8:04 PM

$LPCN fyi https://x.com/persimmonti/status/2018120343425081443?s=61

0 · Reply

ITF Feb. 2 at 4:50 PM

$LPCN LPCN becoming a hedge against the market. lol

0 · Reply

Ma_pooperz Jan. 29 at 7:07 PM

$LPCN Nothing about this stock's upcoming catalysts have changed. We are getting closer to April mark it.

0 · Reply

NothnSpecial Jan. 29 at 4:30 PM

$LPCN wish I could buy some call options here

0 · Reply

dbatech99 Jan. 28 at 6:17 PM

$LPCN eh. This is not the answer I'm looking for.

0 · Reply

amazingcrwns Jan. 28 at 4:22 PM

$LPCN Bought the dip, just a small swing position.

0 · Reply

Lipocine Announces Completion of Enrollment and Dosing in Phase 3 Trial of LPCN 1154 in Postpartum Depression (PPD)

Jan 12, 2026, 8:00 AM EST - 22 days ago

Lipocine Reports Encouraging Progress Post Second Interim Safety Review in Phase 3 Trial of LPCN 1154 in Postpartum Depression (PPD)

Dec 16, 2025, 8:00 AM EST - 7 weeks ago

Lipocine's PPD Phase 3 Study (LPCN 1154) Hits 80% Enrollment Milestone

Nov 18, 2025, 8:00 AM EST - 2 months ago

Lipocine Highlights Promising Interim Safety Profile in Phase 3 Trial of LPCN 1154 in Postpartum Depression (PPD)

Nov 6, 2025, 8:00 AM EST - 3 months ago

Lipocine Announces Financial Results for the Third Quarter Ended September 30, 2025

Nov 4, 2025, 8:00 AM EST - 3 months ago

Lipocine Presents LPCN 2401 Clinical Data at ObesityWeek®

Sep 30, 2025, 8:00 AM EDT - 4 months ago

Lipocine Provides Progress Update on LPCN 1154 Phase 3 Clinical Trial in Postpartum Depression (PPD)

Sep 5, 2025, 4:30 PM EDT - 5 months ago

Lipocine to Present at H.C. Wainwright 27th Annual Global Investment Conference

Aug 26, 2025, 8:00 AM EDT - 5 months ago

Lipocine Announces LPCN 2101 Abstracts Accepted for Presentation at AES 2025

Aug 5, 2025, 8:00 AM EDT - 6 months ago

Lipocine Announces Financial Results for the Second Quarter Ended June 30, 2025

Jun 26, 2025, 8:00 AM EDT - 7 months ago

Lipocine Announces First Patient Dosed in Phase 3 Clinical Trial for LPCN 1154 in Postpartum Depression

Jun 23, 2025, 8:00 AM EDT - 8 months ago

Lipocine to Host Virtual R&D Investor Event to Discuss LPCN 1154 (BRLIZIO™) as a Treatment for Postpartum Depression on July 9, 2025

Jun 9, 2025, 8:00 AM EDT - 8 months ago

Lipocine Announces Filing of New Drug Submission for TLANDO® in Canada

May 22, 2025, 8:00 AM EDT - 9 months ago

Lipocine's LPCN 1148 Highlighted in the June 2025 Edition of Hepatology

May 14, 2025, 8:00 AM EDT - 9 months ago

Lipocine to Present at A.G.P.'s Annual Healthcare Company Showcase

May 8, 2025, 8:00 AM EDT - 9 months ago

Lipocine Announces Financial Results for the First Quarter Ended March 31, 2025

May 6, 2025, 8:00 AM EDT - 9 months ago

Lipocine Announces License and Supply Agreement for TLANDO® in Brazil

Mar 26, 2025, 8:00 AM EDT - 11 months ago

Lipocine Announces Initiation of Outpatient Phase 3 Postpartum Depression Trial of LPCN 1154

Mar 13, 2025, 8:00 AM EDT - 11 months ago

Lipocine Announces Financial Results for the Full Year Ended December 31, 2024

Mar 12, 2025, 8:00 AM EDT - 11 months ago

Lipocine Announces FDA Labeling Changes for Testosterone Products

Feb 6, 2025, 8:00 AM EST - 1 year ago

Lipocine Receives Updated Regulatory Guidance on LPCN 1154

Dec 17, 2024, 8:00 AM EST - 1 year ago

FDA Grants Fast Track Designation to Lipocine for LPCN 1148 as a Treatment for Sarcopenia in Patients with Decompensated Cirrhosis

Nov 18, 2024, 8:00 AM EST - 1 year ago

Lipocine Announces Publication and Discussion of LPCN 1148 Manuscript at The Liver Meeting 2024 Editor's Cut Session

Nov 7, 2024, 8:00 AM EST - 1 year ago

Lipocine Announces Financial Results for the Third Quarter Ended September 30, 2024

Oct 31, 2024, 8:00 AM EDT - 1 year ago

Lipocine Announces Distribution and License Agreement with SPC Korea to Commercialize TLANDO® in South Korea

Oct 10, 2024, 8:00 AM EDT - 1 year ago

Lipocine Announces Positive Oral Brexanolone Quantitative EEG Results

Oct 8, 2024, 8:00 AM EDT - 1 year ago

Lipocine Announces Supply and Distribution Agreement with Pharmalink to Commercialize TLANDO® in the Gulf Cooperation Council (GCC) Countries

Oct 2, 2024, 8:00 AM EDT - 1 year ago

Lipocine to Host Virtual KOL Event on LPCN 2401 for Improved Body Composition in Obesity Management on October 16, 2024

Sep 30, 2024, 8:00 AM EDT - 1 year ago

Lipocine to Present at H.C. Wainwright 8th Annual MASH Investor Conference

Sep 5, 2024, 8:00 AM EDT - 1 year ago

Lipocine Announces Phase 2 Data on LPCN 2401 to be Presented at ObesityWeek®

Aug 27, 2024, 8:00 AM EDT - 1 year ago

Lipocine to Present at H.C. Wainwright 26th Annual Global Investment Conference

Aug 8, 2024, 8:00 AM EDT - 1 year ago

Lipocine Announces Financial Results for the Second Quarter Ended June 30, 2024

Jun 25, 2024, 8:00 AM EDT - 1 year ago

Lipocine Announces LPCN 1154 Meets Bioequivalence with IV Brexanolone in Pivotal Study

Jun 10, 2024, 8:00 AM EDT - 1 year ago

Lipocine Presents 52 Week Results from LPCN 1148 Phase 2 Study in Late Breaking Session at EASL Congress 2024

May 9, 2024, 8:00 AM EDT - 1 year ago

Lipocine Announces Financial Results for the First Quarter Ended March 31, 2024

May 8, 2024, 8:00 AM EDT - 1 year ago

Lipocine Announces Late Breaking Oral Presentation of Data from the Phase 2 Study of LPCN 1148 at EASL Congress 2024

May 1, 2024, 8:00 AM EDT - 1 year ago

Lipocine Announces Completion of Dosing in Pivotal Study of Postpartum Depression Candidate, LPCN 1154

Apr 11, 2024, 7:00 AM EDT - 1 year ago

Lipocine Announces Positive LPCN 2401 Clinical Results Showing Improved Body Composition in Participants with Obesity

Mar 28, 2024, 8:00 AM EDT - 2 years ago

Lipocine Announces Positive Week 52 Results from LPCN 1148 Phase 2 Study in Patients with Cirrhosis

Mar 25, 2024, 8:00 AM EDT - 2 years ago

Lipocine Announces First Cohort Dosed in Pivotal Study of LPCN 1154

Mar 7, 2024, 8:00 AM EST - 2 years ago

Lipocine Announces Financial Results for the Full Year Ended December 31, 2023

Mar 6, 2024, 8:00 AM EST - 2 years ago

Lipocine to Present at 36th Annual Roth Conference

Feb 6, 2024, 8:00 AM EST - 2 years ago

Lipocine Announces Confirmation of Dosing Regimen for Pivotal Study of LPCN 1154

Feb 2, 2024, 8:00 AM EST - 2 years ago

Lipocine Announces Continued Commercialization of TLANDO® through Verity Pharmaceuticals

Jan 18, 2024, 8:00 AM EST - 2 years ago

Lipocine and Verity Pharma Enter into License Agreement for TLANDO® Franchise in the U.S. and Canada

Dec 19, 2023, 8:00 AM EST - 2 years ago

Lipocine to Present at Biotech Showcase 2024

Nov 13, 2023, 2:45 PM EST - 2 years ago

Lipocine Releases Late Breaking Presentation on LPCN 1148 Phase 2 Results at The Liver Meeting® 2023

Nov 8, 2023, 8:00 AM EST - 2 years ago

Lipocine Announces Financial Results for the Third Quarter Ended September 30, 2023

Nov 1, 2023, 8:00 AM EDT - 2 years ago

Lipocine to Present Clinical Data on LPCN 1148 at The Liver Meeting® 2023

Oct 26, 2023, 8:00 AM EDT - 2 years ago

Lipocine Completes Successful Meeting with FDA on LPCN 1154 in Postpartum Depression

Ma_pooperz Feb. 3 at 9:38 PM

0 · Reply

az2001 Feb. 3 at 7:48 PM

$LPCN Took this opportunity to load up some more before upcoming catalysts

2 · Reply

JackLewisLPCN Feb. 3 at 6:44 PM

3 · Reply

dbatech99 Feb. 2 at 11:21 PM

$LPCN islands in the stream chart? 🤮

0 · Reply

steven1x Feb. 2 at 8:04 PM

$LPCN fyi https://x.com/persimmonti/status/2018120343425081443?s=61

0 · Reply

ITF Feb. 2 at 4:50 PM

$LPCN LPCN becoming a hedge against the market. lol

0 · Reply

Ma_pooperz Jan. 29 at 7:07 PM

$LPCN Nothing about this stock's upcoming catalysts have changed. We are getting closer to April mark it.

0 · Reply

NothnSpecial Jan. 29 at 4:30 PM

$LPCN wish I could buy some call options here

0 · Reply

dbatech99 Jan. 28 at 6:17 PM

$LPCN eh. This is not the answer I'm looking for.

0 · Reply

amazingcrwns Jan. 28 at 4:22 PM

$LPCN Bought the dip, just a small swing position.

0 · Reply

Roy111 Jan. 28 at 4:07 PM

$LPCN

0 · Reply

amazingcrwns Jan. 28 at 3:29 PM

$LPCN

1 · Reply

Ma_pooperz Jan. 27 at 7:05 PM

$LPCN Volume slowing down, scalpers and scaredy cats leaving, buyers holding and waiting.

1 · Reply

agarfield Jan. 27 at 4:42 PM

$LPCN I wish you all the best Patel, 20 years going at this and most potential for the company thus far, seems like we are getting to a finale of sorts. Hopefully he gets his cake and the rest of us get to share some slices.

0 · Reply

dbatech99 Jan. 27 at 4:00 PM

$LPCN time for the next leg up... LFG

0 · Reply

Ma_pooperz Jan. 26 at 6:10 PM

$LPCN Market taking a huge poo poo but this one didnt even touch below 10.70 today, I'm excited.

1 · Reply

ITF Jan. 26 at 5:21 PM

$LPCN enjoy the silence...

0 · Reply

OracleofOntario Jan. 26 at 4:26 PM

$LPCN what are the near term catalysts for this stock?

1 · Reply

Ma_pooperz Jan. 26 at 4:06 AM

$LPCN Biotech looking good for Monday, crypto teetering on big fall, lets move some capital again here. New support found

0 · Reply

dbatech99 Jan. 24 at 12:26 AM

$LPCN I bashed this thing for years and rightfully so. But I didn't dump it. I like what I see now 👍

0 · Reply

Ma_pooperz Jan. 23 at 8:58 PM

$LPCN $LPCN If you wanted evidence this stock has legs, today was it. Up ~2–3x recently and the pullback was only ~10–20% — on a red market. No panic, no volume dump. Buyers never left the room.

0 · Reply

dbatech99 Jan. 23 at 5:36 PM

$AMD $LPCN if you whack a few years off the chart... this a beautiful thing. I like where it's goin'

0 · Reply

Market Cap	49.97M
Revenue (ttm)	11.20M
Net Income (ttm)	10,000.00
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.09%
Debt to Equity Ratio	0.00

Volume	64,900
Avg Vol	135,452
Day's Range	N/A - N/A
Shares Out	5.55M
Stochastic %K	11%
Beta	0.92
Analysts	Sell
Price Target	$10.88